Back

 

PRESS RELEASE

For Immediate Release

Contact: Chris Tofalli
Phone: 914-834-4334

Linden to Add Focused Health Solutions to Portfolio

Healthcare and Life Science-Focused Private Equity Firm to Acquire Leading Provider of Disease Management Services

Chicago, Illinois (June 1, 2006) - Linden LLC, a private equity firm that focuses on investments in the healthcare and life science sector, announced today that it has acquired Focused Health Solutions, Inc. (“FHS”), a leading provider of disease management services located in Deerfield, Illinois. Terms of the transaction were not disclosed.

Founded in 2000, FHS has become one of the ten largest independent companies in the growing disease management industry. FHS has over 130 employees who work primarily with self-insured Fortune 1000 companies to reduce healthcare costs through highly targeted disease management programs. FHS designs a personalized program for each of its clients’ employees that sets goals, encourages healthy behaviors and reduces employee use of high-cost medical resources. FHS offers its enrollees a unique disease management model built upon: i) opt-in enrollment, ii) remote telehealth monitoring and iii) frequent nurse interactions. FHS employs a “high touch” approach whereby its staff of experienced nurses interacts directly with enrollees.

"We are pleased to join the growing $1.2 billion disease management industry through our investment in Focused Health Solutions,” said Tony Davis, Managing Director at Linden. “We are particularly excited to partner with the management team as FHS enters a new phase of growth as a stand alone entity. FHS’s customized approach and exclusive focus on self-insured employers have positioned it well to capitalize on employers’ concerns over rising healthcare costs. We look forward to supporting the team as they look to further broaden FHS’s service offering and add to its blue chip roster of clients."

“Linden’s investment in FHS demonstrates our firm’s targeted strategy of investing in non-core divisions of healthcare companies where our operating expertise enables us to partner with management teams to enhance value,” said Eric Larson, Founder and Managing Director of Linden. “Our long-standing relationships with its management team, our ability to consummate the transaction quickly, and our industry knowledge made us the appropriate partner for FHS.”

Merrill Lynch Capital provided the Senior Credit Facility and Babson Capital Management LLC provided mezzanine financing for the transaction.

About Focused Health Solutions, Inc.

Focused Health Solutions is a leading national provider of customized disease management services to large, self-insured employers. Founded in 2000, the Deerfield, IL based company has a senior management team with over 100 years of collective experience in the healthcare industry and boasts a blue chip customer base. FHS combines innovative data analysis tools, disease-specific clinical pathways, proprietary telehealth technology, and deep clinical expertise to reduce client healthcare costs for employees, their dependents, and pre-Medicare retirees who have chronic health conditions. The Company’s programs are targeted toward individuals who have been diagnosed with costly, chronic medical conditions – such as asthma, diabetes, coronary artery disease, hypertension, behavioral disorders, and back and neck pain – that can be managed effectively by a comprehensive, closely-monitored disease management program. The FHS disease management model integrates sophisticated and proprietary systems with care management algorithms and experienced nursing personnel organized by disease category to produce quantifiable health and economic benefits for its program enrollees and employer clients. For more information visit www.focusedhealthsolutions.com.

About Linden LLC

Linden is a private equity group focused exclusively on the healthcare and life science industries. Formed in 2002 as a continuation of a successful investment strategy developed by its principals at First Chicago Equity Capital (“FCEC”), Linden’s strategy is based upon three key elements: i) a healthcare industry specialization, ii) an Operating Partner-focused model and iii) a foundation of corporate relationships. In addition to investing in independent businesses, Linden’s expertise is in transforming corporate-controlled, non-core operations into entrepreneurial, independent businesses. To pursue healthcare and life science buyout opportunities of all sizes, Linden leverages both its own capital through Linden Capital Partners for middle market deals and that of Madison Dearborn Partners through a formal alliance for larger transactions. For additional information about Linden, please visit www.lindenllc.com.

About Merrill Lynch Capital

Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., is a leading commercial finance business providing a broad range of structured financing solutions to middle market companies nationwide. Based in Chicago and with regional offices throughout the country, Merrill Lynch Capital is focused on four market segments—corporate finance, equipment finance, healthcare finance and real estate finance. The Healthcare Finance Group of Merrill Lynch Capital provides senior financing solutions for middle market healthcare companies, offering cash flow, asset, life sciences related and real estate based credit facilities and junior secured debt, and equity co-investments. The typical transaction size for senior debt is between $10 million and $250 million.

About Babson Capital

Babson Capital and its subsidiaries manage over $94 billion as of March 31, 2006 for large investors in the U.S. and abroad. The firm offers a wide range of absolute return, co-investing, financing and customized mandates utilizing equity, fixed-income and derivative instruments. Based in Boston and Springfield, Massachusetts, the firm has six additional offices in the U.S. and an indirect subsidiary, Babson Capital Europe Limited, in London. Babson Capital is a member of the MassMutual Financial Group.

###

 
View or download a printable version of this article. (21.9k)

 

 

 

 

 

 

 
Rights and Usage